Screen Reader Access   

Patent Licensing Details

Technology reference number: 201811032275
First Published on: NA
Title of the technology: A pharmaceutical composition for the treatment of TH17 cells mediated autoimmune diseases and uses thereof.
Technology Brief: NA
Potential Application(s): NA
Advantage(s): NA
IP status: Indian, Provisional
Development status: NA
Researcher(s): NA
Owner(s): THSTI
Last date to receive interest:
Image(s): NA